Nicotinamide Riboside vs. Nicotinamide Mononucleotide - dosing and effects on NAD+ | David Sinclair

The Omega-3 Supplementation Guide

A blueprint for choosing the right fish oil supplement — filled with specific recommendations, guidelines for interpreting testing data, and dosage protocols.

Your subscription could not be saved. Please try again.
Please check your email to confirm your subscription and get The Omega-3 Supplementation Guide!

You'll also receive updates from Rhonda & FoundMyFitness

Two NAD+ precursors, nicotinamide riboside and nicotinamide mononucleotide, have been shown to ameliorate age-associated diseases in animals. They are well-tolerated at high doses and effectively raise NAD+ levels. Evidence suggests that these molecules, often referred to as "NAD+ boosters," may increase levels of NAD+ in humans, too; however, the doses used in some of the studies equate to far less than what was provided in the rodent studies. Currently, only nicotinamide riboside has been shown to raise plasma NAD+ levels and may possibly have beneficial health effects in humans. Future research, focused on "super boosters," may have relevance for treating complex diseases such as diabetes, heart disease, cancer, and Alzheimer's. In this clip, Dr. David Sinclair discusses the current state of research on the NAD+ boosters nicotinamide riboside and nicotinamide mononucleotide.

Get email updates with the latest curated healthspan research

Support our work

Every other week premium members receive a special edition newsletter that summarizes all of the latest healthspan research.

Become a premum member and get access to all our member benefits starting at $15/mo. Sign up for an annual subscription and receive an additional 15% discount.

Aging Videos